Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination

Multiple sclerosis (MS) is a chronic demyelinating disease of unknown etiology in which tissue pathology suggests both immune-dependent attacks to oligodendroglia and primary oligodendrocyte demise. The endocannabinoid system has been crucially involved in the control of autoimmune demyelination and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biochem Pharmacol
Autors principals: Manterola, Andrea, Bernal-Chico, Ana, Cipriani, Raffaela, Canedo-Antelo, Manuel, Moreno-García, Álvaro, Martín-Fontecha, Mar, Pérez-Cerdá, Fernando, Sánchez-Gómez, María Victoria, Ortega-Gutiérrez, Silvia, Brown, J Mark, Hsu, Ku-Lung, Cravatt, Benjamin, Matute, Carlos, Mato, Susana
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6239900/
https://ncbi.nlm.nih.gov/pubmed/30075103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2018.07.042
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars